Anti-bacterial activity of intermittent preventive treatment of malaria in pregnancy: comparative in vitro study of sulphadoxine-pyrimethamine, mefloquine, and azithromycin
Open Access
- 29 October 2010
- journal article
- research article
- Published by Springer Nature in Malaria Journal
- Vol. 9 (1) , 303
Abstract
Background: Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine (SP) is recommended for the prevention of malaria in pregnancy in sub-Saharan Africa. Increasing drug resistance necessitates the urgent evaluation of alternative drugs. Currently, the most promising candidates in clinical development are mefloquine and azithromycin. Besides the anti-malarial activity, SP is also a potent antibiotic and incurs significant anti-microbial activity when given as IPTp - though systematic clinical evaluation of this action is still lacking. Methods: In this study, the intrinsic anti-bacterial activity of mefloquine and azithromycin was assessed in comparison to sulphadoxine-pyrimethamine against bacterial pathogens with clinical importance in pregnancy in a standard microdilution assay. Results: SP was highly active against Staphylococcus aureus and Streptococcus pneumoniae. All tested Gram-positive bacteria, except Enterococcus faecalis, were sensitive to azithromycin. Additionally, azithromycin was active against Neisseria gonorrhoeae. Mefloquine showed good activity against pneumococci but lower in vitro action against all other tested pathogens. Conclusion: These data indicate important differences in the spectrum of anti-bacterial activity for the evaluated anti-malarial drugs. Given the large scale use of IPTp in Africa, the need for prospective clinical trials evaluating the impact of antibiotic activity of anti-malarials on maternal and foetal health and on the risk of promoting specific drug resistance of bacterial pathogens is discussed.Keywords
This publication has 26 references indexed in Scilit:
- Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancyMalaria Journal, 2008
- A Randomized, Controlled Trial of Intermittent Preventive Treatment with Sulfadoxine‐Pyrimethamine, Amodiaquine, or the Combination in Pregnant Women in GhanaThe Journal of Infectious Diseases, 2008
- Antimalarial Therapy Selection for Quinolone Resistance among Escherichia coli in the Absence of Quinolone Exposure, in Tropical South AmericaPLOS ONE, 2008
- Intermittent preventive treatment for the prevention of malaria during pregnancy in high transmission areasMalaria Journal, 2007
- In Vitro Activity and Interaction of Clindamycin Combined with Dihydroartemisinin against Plasmodium falciparumAntimicrobial Agents and Chemotherapy, 2003
- Fluoroquinolone Resistance in Neisseria gonorrhoeaeEmerging Infectious Diseases, 1997
- Antigonococcal activity of 11 drugs used for therapy or prophylaxis of malariaDiagnostic Microbiology and Infectious Disease, 1995
- Malaria infection of the placenta in The Gambia, West Africa; its incidence and relationship to stillbirth, birthweight and placental weightTransactions of the Royal Society of Tropical Medicine and Hygiene, 1983
- Co-trimoxazole (Trimethoprim-sulfamethoxazole) An Updated Review of its Antibacterial Activity and Clinical EfficacyDrugs, 1982
- The effects of mefloquine onLife Sciences, 1979